140 related articles for article (PubMed ID: 25812109)
1. Human parvovirus 4 infection among mothers and children in South Africa.
Matthews PC; Sharp CP; Malik A; Gregory WF; Adland E; Jooste P; Goulder PJ; Simmonds P; Klenerman P
Emerg Infect Dis; 2015 Apr; 21(4):713-5. PubMed ID: 25812109
[No Abstract] [Full Text] [Related]
2. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
[TBL] [Abstract][Full Text] [Related]
3. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
[TBL] [Abstract][Full Text] [Related]
4. [Antibodies against human parvovirus B19 in the Madrid community].
de Ory F; Pachón I; Ramírez R; Echevarría JM
Enferm Infecc Microbiol Clin; 1999; 17(7):364-5. PubMed ID: 10535193
[No Abstract] [Full Text] [Related]
5. Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan.
Chen MY; Yang SJ; Hung CC
Emerg Infect Dis; 2011 Oct; 17(10):1954-6. PubMed ID: 22000381
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
[TBL] [Abstract][Full Text] [Related]
7. Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa.
Sharp CP; Vermeulen M; Nébié Y; Djoko CF; LeBreton M; Tamoufe U; Rimoin AW; Kayembe PK; Carr JK; Servant-Delmas A; Laperche S; Harrison GL; Pybus OG; Delwart E; Wolfe ND; Saville A; Lefrère JJ; Simmonds P
Emerg Infect Dis; 2010 Oct; 16(10):1605-7. PubMed ID: 20875290
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
9. Serodiagnosis of primary infections with human parvovirus 4, Finland.
Lahtinen A; Kivelä P; Hedman L; Kumar A; Kantele A; Lappalainen M; Liitsola K; Ristola M; Delwart E; Sharp C; Simmonds P; Söderlund-Venermo M; Hedman K
Emerg Infect Dis; 2011 Jan; 17(1):79-82. PubMed ID: 21192859
[TBL] [Abstract][Full Text] [Related]
10. [A seroepidemiologic study of human parvovirus B19 infection in children].
Eiros Bouza JM; Bachiller Luque MR; Ochoa Sangrador C; Ortiz de Lejarazu R
An Esp Pediatr; 1999 Jan; 50(1):101-2. PubMed ID: 10083659
[No Abstract] [Full Text] [Related]
11. Prevalence of human parvovirus B19 and TT virus in a group of young haemophiliacs in South Africa.
Rubinstein R; Karabus CD; Smuts H; Kolia F; Van Rensburg EJ
Haemophilia; 2000 Mar; 6(2):93-7. PubMed ID: 10781195
[TBL] [Abstract][Full Text] [Related]
12. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
[TBL] [Abstract][Full Text] [Related]
13. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus PARV4 visualization and detection.
Tuke PW; Parry RP; Appleton H
J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
[TBL] [Abstract][Full Text] [Related]
15. Human parvovirus 4 in nasal and fecal specimens from children, Ghana.
Drexler JF; Reber U; Muth D; Herzog P; Annan A; Ebach F; Sarpong N; Acquah S; Adlkofer J; Adu-Sarkodie Y; Panning M; Tannich E; May J; Drosten C; Eis-Hübinger AM
Emerg Infect Dis; 2012 Oct; 18(10):1650-3. PubMed ID: 23018024
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 antibodies in immunocompromized children in Thailand.
Suandork P; Theamboonlers A; Likitnukul S; Hirsch P; Poovorawan Y
Asian Pac J Allergy Immunol; 2000 Sep; 18(3):161-4. PubMed ID: 11270472
[TBL] [Abstract][Full Text] [Related]
17. Human parvovirus 4 infection, Cameroon.
Lavoie M; Sharp CP; Pépin J; Pennington C; Foupouapouognigni Y; Pybus OG; Njouom R; Simmonds P
Emerg Infect Dis; 2012 Apr; 18(4):680-3. PubMed ID: 22469425
[TBL] [Abstract][Full Text] [Related]
18. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Maple PA; Beard S; Parry RP; Brown KE
Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
[TBL] [Abstract][Full Text] [Related]
19. Low seroprevalence of parvovirus B19 in Taiwanese children and young adults.
Su WJ; Ni YH; Liu DP; Chiou LS; Cheng WY; Wu JS; Lu CY
Pediatr Neonatol; 2010 Oct; 51(5):265-8. PubMed ID: 20951355
[TBL] [Abstract][Full Text] [Related]
20. Human parvovirus 4 infection in low- and high-risk French individuals.
Servant-Delmas A; Laperche S; Lionnet F; Sharp C; Simmonds P; Lefrère JJ
Transfusion; 2014 Mar; 54(3):744-5. PubMed ID: 24617588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
